Intratumoral erythroblastic islands restrain anti-tumor immunity in hepatoblastoma
暂无分享,去创建一个
Ruidong Xue | Shuling Chen | S. Peng | M. Kuang | Yuanqi Wang | Juncheng Liu | Lu-yao Zhou | Huadong Chen | Zhichong Zhang | J. She | Hong-ye Jiang | Xiao-fei Liu | Xuxin Ren | Ji Wang | Juan Jiang | Xiao Xiang | Guopei Zhang
[1] Wei Wu,et al. Single‐cell transcriptomics uncovers cellular architecture and developmental trajectories in hepatoblastoma , 2022, Hepatology.
[2] Bruce Wang,et al. Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids , 2022, Nature Communications.
[3] M. Krailo,et al. Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431. , 2022, The Lancet. Oncology.
[4] Brady Bernard,et al. Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers. , 2022, Cancer cell.
[5] Xueda Hu,et al. Immune phenotypic linkage between colorectal cancer and liver metastasis. , 2022, Cancer cell.
[6] K. Rejniak,et al. TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8+ T cell and XCR1+ dendritic cell spatial co-localization , 2022, Journal for ImmunoTherapy of Cancer.
[7] Xinhua Lin,et al. Modeling hepatoblastoma development with human fetal liver organoids reveals YAP1 activation is sufficient for tumorigenesis , 2021, Protein & Cell.
[8] Dawei Jiang,et al. Characterizing Intercellular Communication of Pan-Cancer Reveals SPP1+ Tumor-Associated Macrophage Expanded in Hypoxia and Promoting Cancer Malignancy Through Single-Cell RNA-Seq Data , 2021, Frontiers in Cell and Developmental Biology.
[9] Xueda Hu,et al. Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer. , 2021, Cancer cell.
[10] J. Wolchok,et al. Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways , 2021, Nature Reviews Clinical Oncology.
[11] Elisabeth F. Heuston,et al. Transitions in lineage specification and gene regulatory networks in hematopoietic stem/progenitor cells over human development , 2021, Cell reports.
[12] Ruibin Xi,et al. Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level. , 2021, Cancer discovery.
[13] Xiaochen Bo,et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data , 2021, Innovation.
[14] A. Regev,et al. TIM-3 restrains anti-tumour immunity by regulating inflammasome activation , 2021, Nature.
[15] John Hale,et al. Comprehensive phenotyping of erythropoiesis in human bone marrow: Evaluation of normal and ineffective erythropoiesis , 2021, American journal of hematology.
[16] R. Bourgon,et al. Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer. , 2021, Cancer cell.
[17] J. Zucman‐Rossi,et al. Integrated genomic analysis identifies driver genes and cisplatin-resistant progenitor phenotype in pediatric liver cancer. , 2021, Cancer discovery.
[18] Yongping Song,et al. Erythroblastic Island Macrophages Shape Normal Erythropoiesis and Drive Associated Disorders in Erythroid Hematopoietic Diseases , 2021, Frontiers in Cell and Developmental Biology.
[19] Jun Yao,et al. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy , 2021, Nature Communications.
[20] Xueda Hu,et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells , 2021, Cell.
[21] Huanming Yang,et al. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma , 2020, Cell.
[22] M. Rojas,et al. Human Lung Resident Macrophages Co-localize with and Provide Co-stimulation to PD1hi Tissue Resident Memory T Cells. , 2020, American journal of respiratory and critical care medicine.
[23] Xiangyuan Wu,et al. Intratumoral CD45+CD71+ erythroid cells induce immune tolerance and predict tumor recurrence in hepatocellular carcinoma. , 2020, Cancer letters.
[24] Huiying Liang,et al. Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia , 2020, Cell.
[25] Raphael Gottardo,et al. Integrated analysis of multimodal single-cell data , 2020, Cell.
[26] Lihua Zhang,et al. Inference and analysis of cell-cell communication using CellChat , 2020, Nature Communications.
[27] C. Hillyer,et al. Putative regulators for the continuum of erythroid differentiation revealed by single-cell transcriptome of human BM and UCB cells , 2020, Proceedings of the National Academy of Sciences.
[28] S. Elahi,et al. Immunological consequences of extramedullary erythropoiesis: immunoregulatory functions of CD71+ erythroid cells , 2020, Haematologica.
[29] S. Cairo,et al. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications. , 2020, Journal of hepatology.
[30] R. Alaggio,et al. Hepatoblastoma and Pediatric Hepatocellular Carcinoma: An Update , 2020, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[31] T. Schumacher,et al. CD8+ T cell states in human cancer: insights from single-cell analysis , 2020, Nature Reviews Cancer.
[32] D. Mills,et al. Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline. , 2019, The Lancet. Child & adolescent health.
[33] B. Geoerger,et al. Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial. , 2019, The Lancet. Oncology.
[34] K. Hutchinson,et al. Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1-2 study. , 2019, The Lancet. Oncology.
[35] V. Kuchroo,et al. TIM3 comes of age as an inhibitory receptor , 2019, Nature Reviews Immunology.
[36] David McDonald,et al. Decoding human fetal liver haematopoiesis , 2019, Nature.
[37] E. Mardis,et al. Immunotherapeutic Challenges for Pediatric Cancers , 2019, Molecular therapy oncolytics.
[38] Yaomei Wang,et al. Identification and transcriptome analysis of erythroblastic island macrophages. , 2019, Blood.
[39] Paul J. Hoffman,et al. Comprehensive Integration of Single-Cell Data , 2018, Cell.
[40] Aaron M. Newman,et al. Single-cell transcriptional diversity is a hallmark of developmental potential , 2019, Science.
[41] R. Atun,et al. Estimating the total incidence of global childhood cancer: a simulation-based analysis. , 2019, The Lancet. Oncology.
[42] S. Imbeaud,et al. APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures , 2019, Oncoimmunology.
[43] J. Poynter,et al. Trends in International Incidence of Pediatric Cancers in Children Under 5 Years of Age: 1988–2012 , 2019, JNCI cancer spectrum.
[44] Andrew J. Hill,et al. The single cell transcriptional landscape of mammalian organogenesis , 2019, Nature.
[45] Fan Zhang,et al. Fast, sensitive, and accurate integration of single cell data with Harmony , 2018, bioRxiv.
[46] Xueda Hu,et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer , 2018, Nature.
[47] Laura Pearce,et al. Trends in the global immuno-oncology landscape , 2018, Nature Reviews Drug Discovery.
[48] F. Marincola,et al. Evolution of Metastases in Space and Time under Immune Selection , 2018, Cell.
[49] Alistair L. J. Symonds,et al. Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells , 2018, Nature Medicine.
[50] Boxi Kang,et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing , 2018, Nature Medicine.
[51] Zev J. Gartner,et al. DoubletFinder: Doublet detection in single-cell RNA sequencing data using artificial nearest neighbors , 2018, bioRxiv.
[52] Matthew D. Young,et al. SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data , 2018, bioRxiv.
[53] Qingqing Wang,et al. Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression , 2018, Cell.
[54] R. Romero,et al. CD71+ erythroid cells from neonates born to women with preterm labor regulate cytokine and cellular responses , 2018, Journal of leukocyte biology.
[55] Michael C. Heinold,et al. The landscape of genomic alterations across childhood cancers , 2018, Nature.
[56] Yang Zhang,et al. Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward , 2018, Journal of Hematology & Oncology.
[57] L. Varani,et al. The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells , 2017, EBioMedicine.
[58] N. Cheung,et al. Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies. , 2017, Cancer treatment reviews.
[59] Boxi Kang,et al. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing , 2017, Cell.
[60] L. Miller,et al. Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy , 2017, Journal of Immunotherapy for Cancer.
[61] D. Wheeler,et al. Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups , 2017, Hepatology.
[62] Charles H. Yoon,et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq , 2016, Science.
[63] J. Wolchok,et al. Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors , 2015, Clinical Cancer Research.
[64] Steven L Salzberg,et al. HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.
[65] J. Wolchok,et al. Immune Checkpoint Blockade in Cancer Therapy. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[66] Shawn M. Gillespie,et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.
[67] Tony T. Jiang,et al. Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection , 2013, Nature.
[68] Justin Guinney,et al. GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.
[69] Wei Li,et al. RSeQC: quality control of RNA-seq experiments , 2012, Bioinform..
[70] Guangchuang Yu,et al. clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.
[71] Ching-Hon Pui,et al. Challenging issues in pediatric oncology , 2011, Nature Reviews Clinical Oncology.
[72] D. Zurakowski,et al. Effects of Neoadjuvant Chemotherapy on Hepatoblastoma: A Morphologic and Immunohistochemical Study , 2010, The American journal of surgical pathology.
[73] Martin A. Cheever,et al. The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research , 2009, Clinical Cancer Research.
[74] Soichi Wakatsuki,et al. Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue. , 2008, Journal of molecular biology.
[75] P. Heagerty,et al. Survival Model Predictive Accuracy and ROC Curves , 2005, Biometrics.
[76] Nicholas L. Bormann,et al. scRepertoire: An R-based toolkit for single-cell immune receptor analysis. , 2020, F1000Research.